Home/Filings/4/0000950170-25-004275
4//SEC Filing

Ketchum Steven B 4

Accession 0000950170-25-004275

CIK 0000897448other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 5:00 PM ET

Size

6.3 KB

Accession

0000950170-25-004275

Insider Transaction Report

Form 4
Period: 2025-01-10
Ketchum Steven B
EVP, Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-10+663,878663,878 total
    Exercise: $0.62Exp: 2035-01-10Ordinary Shares (663,878 underlying)
Footnotes (3)
  • [F1]Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
  • [F2]On January 10, 2025, the Reporting Person was granted an option to purchase 663,878 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over eighteen months, with 50% to vest on the first anniversary of the grant date and the remaining balance to vest eighteen months after grant date.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file

Issuer

AMARIN CORP PLC\UK

CIK 0000897448

Entity typeother

Related Parties

1
  • filerCIK 0001289884

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:00 PM ET
Size
6.3 KB